Immatics Biotechnologies Gmbh Stock Probability of Future Stock Price Finishing Over 0.87
| IMTXW Stock | USD 0.40 0.06 13.04% |
Immatics |
Immatics Biotechnologies Target Price Odds to finish over 0.87
The tendency of Immatics Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 0.87 or more in 90 days |
| 0.40 | 90 days | 0.87 | about 82.43 |
Based on a normal probability distribution, the odds of Immatics Biotechnologies to move over $ 0.87 or more in 90 days from now is about 82.43 (This immatics biotechnologies GmbH probability density function shows the probability of Immatics Stock to fall within a particular range of prices over 90 days) . Probability of Immatics Biotechnologies price to stay between its current price of $ 0.40 and $ 0.87 at the end of the 90-day period is about 10.44 .
Assuming the 90 days horizon the stock has the beta coefficient of 1.89 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Immatics Biotechnologies will likely underperform. Additionally Immatics biotechnologies GmbH has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Immatics Biotechnologies Price Density |
| Price |
Predictive Modules for Immatics Biotechnologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Immatics Biotechnologies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immatics Biotechnologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Immatics Biotechnologies Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Immatics Biotechnologies is not an exception. The market had few large corrections towards the Immatics Biotechnologies' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold immatics biotechnologies GmbH, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Immatics Biotechnologies within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -2.36 | |
β | Beta against Dow Jones | 1.89 | |
σ | Overall volatility | 0.88 | |
Ir | Information ratio | -0.22 |
Immatics Biotechnologies Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Immatics Biotechnologies for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Immatics Biotechnologies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Immatics Biotechnologies generated a negative expected return over the last 90 days | |
| Immatics Biotechnologies has high historical volatility and very poor performance | |
| Immatics Biotechnologies has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 54 M. Net Loss for the year was (96.99 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Latest headline from news.google.com: Cantor Fitzgerald Forecasts Higher Earnings for Immatics - MarketBeat |
Immatics Biotechnologies Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Immatics Stock often depends not only on the future outlook of the current and potential Immatics Biotechnologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Immatics Biotechnologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 80.5 M | |
| Cash And Short Term Investments | 425.9 M |
Immatics Biotechnologies Technical Analysis
Immatics Biotechnologies' future price can be derived by breaking down and analyzing its technical indicators over time. Immatics Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of immatics biotechnologies GmbH. In general, you should focus on analyzing Immatics Stock price patterns and their correlations with different microeconomic environments and drivers.
Immatics Biotechnologies Predictive Forecast Models
Immatics Biotechnologies' time-series forecasting models is one of many Immatics Biotechnologies' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Immatics Biotechnologies' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Immatics Biotechnologies
Checking the ongoing alerts about Immatics Biotechnologies for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Immatics Biotechnologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Immatics Biotechnologies generated a negative expected return over the last 90 days | |
| Immatics Biotechnologies has high historical volatility and very poor performance | |
| Immatics Biotechnologies has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 54 M. Net Loss for the year was (96.99 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Latest headline from news.google.com: Cantor Fitzgerald Forecasts Higher Earnings for Immatics - MarketBeat |
Additional Tools for Immatics Stock Analysis
When running Immatics Biotechnologies' price analysis, check to measure Immatics Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics Biotechnologies is operating at the current time. Most of Immatics Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Immatics Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics Biotechnologies' price. Additionally, you may evaluate how the addition of Immatics Biotechnologies to your portfolios can decrease your overall portfolio volatility.